Log in

Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Colectomy risk after acute severe ulcerative colitis (ASUC) has not been compared between Eastern and Western countries. We compared the 1-year colectomy risk after ASUC between Korea and the USA.

Methods

Data on patients admitted for ASUC to five tertiary referral hospitals in Korea and Mount Sinai Hospital, New York, the USA, between January 2015 and January 2019 were reviewed retrospectively. For comparability between groups, a 1:1 propensity score matching (PSM) was performed. The primary outcome was colectomy, and secondary outcomes were mortality, readmission, and venous thromboembolism (VTE) within 1-year of the index admission for ASUC. The risk of each outcome was compared using Cox proportional hazards model in pre-matched cohort and Kaplan–Meier analysis with log-rank test in post-matched cohort.

Results

290 ASUC patients were included in the study (121 Korea, 169 the USA). After PSM, 56 patients were selected in each group with no significant differences in baseline variables. At 1 year after ASUC, colectomy was less common in Korea than in the USA [3 (5.4%) vs. 24 (42.9%), p < 0.001]. The cumulative colectomy risk was significantly higher in the USA than in Korea in pre-matched cohort [adjusted hazard ratio 7.89, 95% confidence interval 3.23 to 19.22] and in post-matched cohort (log-rank p < 0.001), while there was no difference in cumulative risk of mortality, readmission, and VTE.

Conclusion

Colectomy risk within 1 year of ASUC is significantly higher in the USA than in Korea. We observed no differences in mortality, readmission, and VTE between the two groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756–1770.

    Article  Google Scholar 

  2. Bitton A, Buie D, Enns Ret al. Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements Am J Gastroenterol. 2012;107:179–194; author reply 195.

  3. Dinesen LC, Walsh AJ, Protic MN et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4:431–437.

    Article  Google Scholar 

  4. Jain S, Kedia S, Sethi T et al. Predictors of long-term outcomes in patients with acute severe colitis: A northern Indian cohort study. J Gastroenterol Hepatol. 2018;33:615–622.

    Article  Google Scholar 

  5. Ananthakrishnan AN, Issa M, Beaulieu DB et al. History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis. Inflamm Bowel Dis. 2009;15:176–181.

    Article  Google Scholar 

  6. Dong C, Metzger M, Holsbo E, Perduca V, Carbonnel F. Systematic review with meta-analysis: mortality in acute severe ulcerative colitis. Aliment Pharmacol Ther. 2020;51:8–33.

    Article  Google Scholar 

  7. Leeds IL, Sundel MH, Gabre-Kidan A et al. Outcomes for ulcerative colitis with delayed emergency colectomy are worse when controlling for preoperative risk Factors. Dis Colon Rectum. 2019;62:600–607.

    Article  Google Scholar 

  8. Narula N, Jharap B, Colombel JF. Management of severe ulcerative colitis. Curr Treat Options Gastroenterol. 2015;13:59–76.

    Article  Google Scholar 

  9. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657–663.

    Article  Google Scholar 

  10. Liu J, Gao X, Chen Yet al. . Incidence and risk factors for venous thrombosis among patients with inflammatory bowel disease in China: a multicenter retrospective study Intest Res. 2020.

  11. Yang SK. How does the epidemiology of inflammatory bowel disease differ between east and west? A Korean perspective. Inflamm Intest Dis. 2017;2:95–101.

    Article  Google Scholar 

  12. Bernstein CN, Ng SC, Lakatos PL et al. A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease. Inflamm Bowel Dis. 2013;19:2001–2010.

    PubMed  Google Scholar 

  13. Aniwan S, Limsrivilai J, Pongprasobchai S et al. (2021) Temporal trend in the natural history of ulcerative colitis in a country with a low incidence of ulcerative colitis from 2000 through. Intest Res 2018;19:186–193.

    Article  Google Scholar 

  14. Cha JM, Park SH, Rhee KH et al. Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul Korea. Gut. 2020;69:1432–1440.

    Article  CAS  Google Scholar 

  15. Frolkis AD, Dykeman J, Negron ME et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145:996–1006.

    Article  Google Scholar 

  16. Ng SC, Zeng Z, Niewiadomski O et al. Early course of inflammatory bowel disease in a population-based inception cohort study from 8 Countries in Asia and Australia Gastroenterology. 2016;150:86–95 e83; quiz e13–84.

  17. Oh SJ, Shin GY, Soh H et al. Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis Intest Res. 2020.

  18. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974;1:1067–1070.

    Article  CAS  Google Scholar 

  19. Magro F, Gionchetti P, Eliakim R et al. Third european evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis 2017;11:649–670.

    Article  Google Scholar 

  20. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.

    Article  CAS  Google Scholar 

  21. Sandborn WJ, Su C, Sands BE et al. Tofacitinib as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2017;376:1723–1736.

    Article  CAS  Google Scholar 

  22. Travis SP, Farrant JM, Ricketts C et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38:905–910.

    Article  CAS  Google Scholar 

  23. Le Baut G, Kirchgesner J, Amiot A et al. A scoring system to determine patients' risk of colectomy within 1 year after hospital admission for acute severe ulcerative colitis Clin Gastroenterol Hepatol. 2020.

  24. Syal G, Robbins L, Kashani A et al. Hypoalbuminemia and bandemia predict failure of infliximab rescue therapy in acute severe ulcerative colitis. Dig Dis Sci. 2020;66:199–205.

    Article  Google Scholar 

  25. Dalal RS, Osterman MT, Buchner AM, Praestgaard A, Lewis JD, Lichtenstein GR. A user-friendly prediction tool to identify colectomy risk in patients with ulcerative colitis. Inflamm Bowel Dis. 2019;25:1550–1558.

    Article  Google Scholar 

  26. Samuel S, Ingle SB, Dhillon S et al. Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis. Inflamm Bowel Dis. 2013;19:1858–1866.

    PubMed  Google Scholar 

  27. Dias CC, Rodrigues PP, da Costa-Pereira A, Magro F. Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies. J Crohns Colitis. 2015;9:156–163.

    Article  Google Scholar 

  28. Khanna S. Management of Clostridioides difficile infection in patients with inflammatory bowel disease Intest Res. 2020.

  29. Lee HS, Yang SK, Soh JS et al. Short- and long-term outcomes of acute severe ulcerative colitis in Korea: the 1999–2005 cohort. Inflamm Bowel Dis 2015;21:1825–1831.

    Article  Google Scholar 

  30. Oshitani N, Kitano A, Fukushima R et al. Predictive factors for the response of ulcerative colitis patients during the acute-phase treatment. Digestion. 1990;46:107–113.

    Article  CAS  Google Scholar 

  31. Oshitani N, Matsumoto T, **no Y et al. Prediction of short-term outcome for patients with active ulcerative colitis. Dig Dis Sci. 2000;45:982–986.

    Article  CAS  Google Scholar 

  32. Seo M, Okada M, Yao T, Matake H, Maeda K. Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index. J Gastroenterol. 2002;37:29–34.

    Article  Google Scholar 

  33. Reich KM, Chang HJ, Rezaie A et al. The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study. Aliment Pharmacol Ther. 2014;40:629–638.

    Article  CAS  Google Scholar 

  34. Han M, Jung YS, Cheon JH, Park S. Comparison of real-world outcomes of infliximab versus adalimumab in biologic-naive Korean patients with ulcerative colitis: a population-based study. Yonsei Med J. 2020;61:48–55.

    Article  CAS  Google Scholar 

  35. Lee HS, Park SH, Kim SH et al. Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis. Inflamm Bowel Dis. 2016;22:912–918.

    Article  Google Scholar 

  36. Salameh R, Kirchgesner J, Allez M et al. Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids. Aliment Pharmacol Ther. 2020;51:1096–1104.

    Article  CAS  Google Scholar 

  37. Cuppen BV, Pardali K, Kraan MC et al. Polymorphisms in the multidrug-resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment. Rheumatol Int. 2017;37:531–536.

    Article  CAS  Google Scholar 

  38. Lee SS, Kim SY, Kim WY et al. MDR1 genetic polymorphisms and comparison of MDR1 haplotype profiles in Korean and Vietnamese populations. Ther Drug Monit 2005;27:531–535.

    Article  CAS  Google Scholar 

  39. Lee Y, Lee H, Lee H, Jang Y, Kim C. Analytical dietary fiber database for the national health and nutrition survey in Korea. J Food Compos Anal. 2008;21:S35–S42.

    Article  Google Scholar 

  40. Desai MS, Seekatz AM, Koropatkin NM et al. (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 167:1339–1353 e1321.

  41. Nam YD, Jung MJ, Roh SW, Kim MS, Bae JW. Comparative analysis of Korean human gut microbiota by barcoded pyrosequencing. PLoS One 2011;6:e22109.

    Article  CAS  Google Scholar 

  42. Coakley BA, Telem D, Nguyen S, Dallas K, Divino CM. Prolonged preoperative hospitalization correlates with worse outcomes after colectomy for acute fulminant ulcerative colitis. Surgery. 2013;153:242–248.

    Article  Google Scholar 

  43. Randall J, Singh B, Warren BF, Travis SP, Mortensen NJ, George BD. Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications. Br J Surg. 2010;97:404–409.

    Article  CAS  Google Scholar 

  44. Saha SK, Panwar R, Kumar A et al. Early colectomy in steroid-refractory acute severe ulcerative colitis improves operative outcome. Int J Colorectal Dis. 2018;33:79–82.

    Article  Google Scholar 

  45. Weng MT, Park SH, Matsuoka K et al. Incidence and risk factor analysis of thromboembolic events in east asian patients with inflammatory bowel disease, a multinational collaborative study. Inflamm Bowel Dis 2018;24:1791–1800.

    Article  Google Scholar 

  46. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384–413.

    Article  Google Scholar 

  47. Choi CH, Moon W, Kim YS et al. Second Korean guidelines for the management of ulcerative colitis. Intest Res. 2017;15:7–37.

    Article  Google Scholar 

Download references

Funding

This work was supported by grants from the National Research Foundation (NRF) of Korea (NRF-2017R1D1A1B03028512, NRF-2020R1F1A1066115).

Author information

Authors and Affiliations

Authors

Contributions

Guarantor of the article: Eun Soo Kim. ESK and KOK: study design, data collection, data analysis, writing first draft of manuscript. BIJ, EYK, YJL, HSL, JSL, and SKK: collection of clinical data, critical revision of the manuscript, final approval of the version to be submitted. MA, RU, and JFC: study design, data analysis, supervision, critical revision of the manuscript, final approval of the version to be submitted. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Eun Soo Kim.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, E.S., Kim, K.O., Jang, B.I. et al. Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis. Dig Dis Sci 67, 2866–2875 (2022). https://doi.org/10.1007/s10620-021-07130-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-021-07130-y

Keywords

Navigation